PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,326,760 | -48.5% | 139,494 | -14.6% | 0.01% | -47.8% |
| Q2 2023 | $4,513,799 | +60.8% | 163,425 | +33.9% | 0.02% | +53.3% |
| Q1 2023 | $2,806,552 | +32.1% | 122,024 | -37.3% | 0.02% | +25.0% |
| Q4 2022 | $2,124,221 | +31.8% | 194,704 | +1.8% | 0.01% | +9.1% |
| Q3 2022 | $1,612,000 | +219.2% | 191,193 | +568.6% | 0.01% | +175.0% |
| Q2 2020 | $505,000 | – | 28,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |